common.study.topics.clinical

Colchicine in Atrial Fibrillation to Prevent Stroke

common.study.values.description

Colchicine in Atrial Fibrillation to Prevent Stroke

The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Colchicine

Colchicine 0.6mg twice daily

Drug - Placebo

Placebo Colchicine

participant.views.study.view.additional

participant.views.study.view.scientific-title

Targeting Inflammation in Atrial Fibrillation to Prevent Ischemic Stroke: A Feasibility Study Evaluating the Effect of Colchicine on D-dimer and Hs-CRP in Anticoagulated Patients With Atrial Fibrillation

common.study.values.clinical-trial-id

NCT02282098

participant.views.study.view.id

xboONb